Advertisement

Topics

Latest "IN VITRO DIAGNÓSTICA S/A" News Stories

02:14 EDT 23rd September 2018 | BioPortfolio

Here are the most relevant search results for "IN VITRO DIAGNÓSTICA S/A" found in our extensive news archives from over 250 global news sources.

More Information about IN VITRO DIAGNÓSTICA S/A on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about IN VITRO DIAGNÓSTICA S/A for you to read. Along with our medical data and news we also list IN VITRO DIAGNÓSTICA S/A Clinical Trials, which are updated daily. BioPortfolio also has a large database of IN VITRO DIAGNÓSTICA S/A Companies for you to search.

Showing "VITRO DIAGN STICA" News Articles 1–25 of 934

Saturday 22nd September 2018

Chiome Bioscience Inc 4583 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13042018] Prices from USD $250

SummaryChiome Bioscience Inc Chiome Bioscience is a healthcare service company that offers research and development of therapies. The company research and develops antibody drugs for the treatment of autoimmune and inflammatory diseases. Its ADLib system is a monoclonal antibody generating system provides various arrays of antibodies in vitro, without using immunization. Chiome Bioscience uses the...


Friday 21st September 2018

#jobs #lifescience SRG: Project Lead (In Vitro Diagnostics)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: SRG: Project Lead (In Vitro Diagnostics) . DOE: SRG: Project Lead (In Vitro Diagnostics)Do you hold strong experience in the field of In Vitro Diagnostics and looking for … Continue reading → Cet article #jobs #lifescience SRG: Project Lead (In Vitro Diagnostics) e...

Human Egg Precursor Generated in a Dish

Human pluripotent stem cells cradled by a mouse ovarian environment—a sort of living “dish”—differentiated into states that brought the cells close to becoming mature oocytes. The cells, which were evaluated over the course of a months-long experiment, progressed epigenetically toward reproductive competence, suggesting that induced pluripotent stem cells, given the right culture condition...


Hesperos, Inc. Among GrowFL 2018 Florida Companies to Watch

Hesperos, Inc. has announced that it has been named one of the 50 statewide companies expected to see significant growth over the next several years by GrowFL. The 50 companies were selected from more than 500 nominees for Florida Companies to WatchSM, a statewide program managed by economic development group GrowFL, in association with the Edward Lowe Fou...

Thursday 20th September 2018

Scientists have discovered how to predict life of implants without animal testing

(National University of Science and Technology MISIS) An international team of researchers consisting of scientists from NUST MISIS and TU Dortmund University has developed a technology to study the behavior of orthopedic implants in laboratory conditions as close as possible to the human body. The technology is notable for its ethics: the research can be carried out in vitro -- that is, without i...

Volkswagen Vehículos Comerciales en la feria IAA 2018

HANNOVER, Alemania, September 20, 2018 /PRNewswire/ -- El director ejecutivo Dr. Thomas Sedran presenta soluciones para una movilidad sostenible Soluciones de logística y transporte para Read more...

Pancreatic Cancer Therapies May Be Improved through Novel Live-Tumor Imaging Method

Hokkaido University scientists say they have developed a new cell-culture platform that allows them to see never-before-seen behaviors of live cancer cells under the microscope. The observation of these behaviors’ sheds light on the mechanisms behind well-known properties of pancreatic cancer, one of the most lethal malignant tumors, and may lead to the identification of new treatment targe...

Novel Cell-Culture Platform May Lead to Development of Improved Cancer Therapies

Hokkaido University scientists say they have developed a new cell-culture platform that allows them to see never-before-seen behaviors of live cancer cells under the microscope. The observation of these behaviors’ sheds light on the mechanisms behind well-known properties of pancreatic cancer, one of the most lethal malignant tumors, and may lead to the identification of new treatment targe...

Wednesday 19th September 2018

Stream Bio launches novel bioimaging probes with 2BScientific

Stream Bio Ltd, a company that develops and manufactures a range of revolutionary bioimaging molecular probes, has today launched its transformative Conjugated Polymer Nanoparticle (CPN™) products with life science distributors 2BScientific. Current bioimaging products have weak fluorescence and low sensitivities, which often fade prematurely. Stream Bio’s non-toxic molecular bioimagin...

NAD: Sea & Ski Sunscreens May Go ‘Beyond UV,’ But Not To Infrared Zone

Cross Brands Manufacturing’s stingily hand-picked in vitro test results for Sea & Ski sunscreens do not demonstrate a clear, consumer-relevant...   

Senzagen blir först med luftvägstest

Nu presenterar bolaget ett in vitro-test för luftvägsallergier. 

ECVAM evaluation of GARDskin rescheduled to an extra scientific committee meeting in spring 2019

Lund, September 18, 2018 - SenzaGen (Nasdaq First North: SENZA) has been notified by the European Center for the Validation of Alternative Methods (ECVAM) authority that due to time constrains their scientific committee (ESAC) will not be able to evaluate tests in the category ”Test Guidelines on Health Effects”, to which GARDskin belongs, this year. The authority cites high workload...

SenzaGen launches the first in vitro airway allergy test – GARDair – at ESTIV2018

Lund, September 18, 2018 - SenzaGen (Nasdaq First North: SENZA) announced today that the company will launch GARDair, the first in vitro test for airway allergies at ESTIV2018, the 20th International Congress on In Vitro Toxicology. Removing the need for animal testing and opening a completely new market, GARDair is based on the company’s proprietary GARD® technology platform. Using ge...

Tuesday 18th September 2018

Quest International Announces Additional Medical Device Proficiencies – Ophthalmic & Dental

Quest International, Inc., a global leading service provider specializing in depot repairs, field services, and supply chain logistics for medical device manufacturers, announced today the additional proficiencies of Ophthalmic and Dental technologies. Over the years, Quest has on boarded and have become experts in various

Gene Therapy in Oncology [Report Updated: 01062018] Prices from USD $7995

Gene Therapy in OncologySummaryUnlike conventional treatments such as chemotherapy, gene therapy combines reduced treatment duration one time treatment in some cases with higher chances of cure in oncology. This novel therapeutic approach requires direct delivery of genetic material to the patient or in vitro genetic modification of patient cells and subsequent delivery to the patient, which is an...

Roche's NAVIFY decision support portfolio unlocks relevant content from clinical trial and medical publication databases

F. Hoffmann-La Roche Ltd / Roche's NAVIFY decision support portfolio unlocks relevant content from clinical trial and medical publication databases . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Roche launches an app ecosystem with the first two clinical decision support apps The apps que...

Monday 17th September 2018

Efficient and tumor-specific knockdown of MTDH gene attenuates paclitaxel resistance of breast cancer cells both in vivo and in vitro

Drug resistance of paclitaxel (TAX), the first-line chemotherapy drug for breast cancer, was reported to develop in 90% of patients with breast cancer, especially metastatic breast cancer. Investigating the me...

Novel Biased Potent Opioid-Like Agonists as Improved Medications to Treat Chronic and Acute Pain

There are no analgesics to ameliorate chronic pain without adverse side-effects (e.g., respiratory depression, gastrointestinal effects, tolerance, dependence), thus forcing patients into a difficult choice of negative impacts on quality of life. Most of the analgesics used for chronic and acute pain are drugs such as oxycodone, morphine, oxymorphone, and codeine. All of these opioids have been su...

Propofol inhibits parthanatos via ROS–ER–calcium–mitochondria signal pathway in vivo and vitro

Popular Blogger Who Documented Her IVF Journey Dies During Emergency C-Section

(People) – A 30-year-old woman who shared her fertility journey on social media tragically died while undergoing an emergency cesarean section, Spanish news outlet El Mundo reports. Vanessa Fernandez Arango began documenting her in-vitro fertilization experience earlier this year on Instagram … Read More

Oragenics, Inc. to Present Data from Its Lantibiotics Program at the Boulder Peptide Symposium Monday, September 24, 2018

Oragenics, Inc. (NYSE American:OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis (OM), today announced that Dr. Martin Handfield, the company’s senior vice president of discovery research will present data on its lantibiotics program for the treatment of serious and prevalent inf...

DiaSorin Elevates the Discussion of TORCH Infections During Pregnancy in Educational Webinar

Through this webinar, which LabRoots will host October 16, participants will gain a better understanding of the epidemiology and burden of these infectious diseases in pregnancy and newborns. YORBA LINDA, Calif. (PRWEB) September 17, 2018 This webinar, which is sponsored by DiaSorin, will provide an overview on some pathogens that can be transmitted from mother to fetus during pregnancy (prenatal...

Singulex Inc Medical Equipment Deals and Alliances Profile [Report Updated: 18072018] Prices from USD $250

SummarySingulex Inc Singulex is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and physicians in identifying the biomarkers of disease. Singulex's SMC technology offer ultrasensitive lab ...

United Therapeutics Acquires North American Rights to Samumed IPF Candidate SM04646

Samumed said today it has sold North American rights to its Phase I idiopathic pulmonary fibrosis (IPF) candidate SM04646 to United Therapeutics, in a deal that could generate more than $350 million for the privately-held San Diego biotech. SM04646 is a small-molecule inhalable Wnt signaling pathway inhibitor that according to Samumed has generated preclinical data showing anti-fibrotic proper...

Metrion Biosciences makes senior appointments to strengthen its drug discovery leadership team.

Dr Edward Stevens appointed as Head of Drug Discovery, and Dr Andrew Lightfoot as Head of Medicinal Chemistry and Discovery Funding Cambridge, UK, 17 September 2018: Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced it has made two senior appointments to its management team.  Dr Edward Steve...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks